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Sleeping tablet study: The attitude of patients over 65 years to ceasing long term
sleeping tablets
Abstract
The aim of this project was to assess elderly patients’ use and knowledge of sleeping tablets and their
attitude to stopping them.
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Sleeping Tablet
Study

The attitude of patients over 65 years to ceasing
long term sleeping tablets
Background

A circle of silence appears to exist
around sleeping tablet use

Sleeping tablets are prescribed for the
short term treatment of insomnia, yet
are often continued long term. They
have significant adverse health effects in
the elderly, with increased risk of falls,
fractures, road traffic accidents and
cognitive decline.

Elderly patient,
multi-comorbidity
taking nocturnal
benziodiazepines

Project aims
The aim of this project was to assess
elderly patients’ use and knowledge of
sleeping tablets and their attitude to
stopping them.

Often confounding
factor disturbing sleep

Many patients in the study had been taking
the medication for some considerable
time, despite limited benefit.
Sleeping tablets were often started at a
time of stress and issues such as needing
to use the bathroom or pain contributing to
ongoing insomnia.
Previous studies have shown that GPs
may be reluctant to challenge patients
regarding sleeping tablet use because of
anticipated resistance from patients and
time constraints in an appointment.

This specific project was
funded by Coast City Country
General Practice Training.
Researchers:
Dr Fiona Williams, Dr Carl
Mahfouz, Prof Andrew Bonney,
Dr Russell Pearson, Dr Bastian
Seidel, Miss Bridget DijkmansHadley A/Prof Judy Mullan
and Dr Rowena Ivers.
If you have any further queries
regarding this project, please
contact

Seventeen patients aged over 65 from four
Australian general practices took part in
telephone interviews.

Results

This study was conducted by
the Illawarra and Southern
Practice Research Network
(ISPRN) which is co-funded by
the University of Wollongong’s
Graduate School of Medicine
and the Illawarra Health and
Medical Research Institute.

GP perceives
resistance to
stopping medication,
time pressures of
consultation, writes
repeat prescription

Patient perceives
GP to be in approval
of sleeping tablet
use. Unaware of side
effects and addictive
nature - requests repeat
prescription

The majority of patients showed
willingness to cease medication. However,
they did not see a need to as they were
unaware of the side effects and the
addictive nature of sleeping tablets.

Key Findings
•

sleeping tablets are not designed for
the long term treatment of insomnia

•

Patients believed their GP approved the
continued use of sleeping tablets because
of the lack of challenge when requesting
a repeat prescription. This facilitated
ongoing use.

many patients are willing to cease the
medication and are not resistant to
change

•

a thorough sleep history should be
carried out for any patient presenting
with insomnia

Conclusion

•

confounding factors are often the
cause of sleep disturbance, with more
targeted treatments available

•

patients presenting for repeat
prescriptions of sleeping tablets should
have a medication review performed to
discuss side effects, addictive potential,
alternative options and need for
ongoing use.

Spending time with patients presenting for
repeat prescriptions of sleeping tablets,
discussing the cause of sleep disturbance,
potential side effects of medication,
availability of alternative options and
exploring the need for ongoing use may
reduce the use of this potentially harmful
medication in the elderly.

Alyssa Horgan at the Graduate
School of Medicine, University
of Wollongong on (02) 4221
5819.
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